Is Vertex Pharmaceuticals Inc halal to invest in?

As of August 2026, Vertex Pharmaceuticals Inc VRTX.VI is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Vertex Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vertex Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Vertex Pharmaceuticals Inc?

Muslim investors may consider investing in Vertex Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Vertex Pharmaceuticals Inc classified as HALAL?

Musaffa determines the Shariah status of Vertex Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Vertex Pharmaceuticals Inc updated?

The Shariah compliance status of Vertex Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Vertex Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Vertex Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Vertex Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Vertex Pharmaceuticals Inc VRTX.VI

Last Updated: Aug 12, 12:00 AM·WBAG

VRTX.VI Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Vertex Pharmaceuticals Inc is classified as halal.

HALAL

Report Source: undefined Quarter Report

Vertex Pharmaceuticals Inc. Stock Analysis VRTX.VI

Austria Health Care Large Cap

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The company is headquartered in Boston, Massachusetts and currently employs 6,400 full-time employees. The company has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).